Key players in neurodegenerative disorders in focus-New insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS, and multiple sclerosis-24th HUPO BPP Workshop: September 29, 2015, Vancouver, Canada

Proteomics. 2016 Apr;16(7):1047-50. doi: 10.1002/pmic.201600047.

Authors

Andreas Schrötter^{1

2}, Young Mok Park³, Katrin Marcus⁴, Daniel Martins-de-Souza⁵, Peter Nilsson⁶, Fouzi El Magraoui^{1

7}, Helmut E Meyer¹, Lea T Grinberg^{8

9}

Affiliations

¹ Leibniz-Institut für Analytische Wissenschaften-ISAS-e. V, Biomedical Research, Dortmund, Germany.
² Leibniz-Institut für Analytische Wissenschaften-ISAS-e. V, Human Brain Proteomics I, Dortmund, Germany.
³ Center for Cognition and Sociality, Mass Spectrometry Research Center, Korea Basic Science Institute, Chungbuk, Korea.
⁴ Department of Functional Proteomics, Medizinisches Proteom-Center, Ruhr University Bochum, Bochum, Germany.
⁵ University of Campinas, Department of Biochemistry, Campinas, Brazil.
⁶ KTH-Royal Institute of Technology, School of Biotechnology, Stockholm, Schweden.
⁷ Leibniz-Institut für Analytische Wissenschaften-ISAS-e. V, Human Brain Proteomics II, Dortmund, Germany.
⁸ University of São Paulo Medical School, Department of Pathology, Brazil.
⁹ University of California, Department of Neurology, Memory and Aging Center, San Francisco, USA.

PMID: 26872682
DOI: 10.1002/pmic.201600047

Abstract

The HUPO Brain Proteome Project (HUPO BPP) held its 24th workshop in Vancouver, Canada, September 29, 2015. The focus of the autumn workshop was on new insights into the proteomic profile of Alzheimer's disease, schizophrenia, ALS and multiple sclerosis.

Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; Brain Proteome Project; HUPO; Multiple sclerosis; Neurodegeneration; Schizophrenia.

MeSH terms

Canada
Humans
Multiple Sclerosis*
Neurodegenerative Diseases*
Proteome / analysis
Proteomics / education*
Proteomics / organization & administration*
Schizophrenia*

Substances

Proteome